[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350327-105":59,"doc-detail-350327-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-role-of-fosl1-in-inflammatory-bowel-disease-ibd-pathogenesis-and-ibd-associated-tumorigenesis","The Role of FOSL1 in Inflammatory Bowel Disease (IBD) Pathogenesis and IBD-Associated Tumorigenesis","","Inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease, are chronic gastrointestinal inflammatory disorders marked by epithelial barrier dysfunction, immune dysregulation, and elevated cancer risk. Persistent inflammation drives IBD-associated tumorigenesis, while the transcriptional regulators connecting inflammatory signaling to epithelial transformation remain insufficiently defined. FOSL1, an AP-1 transcription factor, integrates inflammatory cues with epithelial homeostasis and cancer progression, shaping proliferation, migration, barrier integrity, immune modulation, and survival, and is linked to malignancy and therapeutic resistance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-role-of-fosl1-in-inflammatory-bowel-disease-ibd-pathogenesis-and-ibd-associated-tumorigenesis/350327/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-role-of-fosl1-in-inflammatory-bowel-disease-ibd-pathogenesis-and-ibd-associated-tumorigenesis/350327.png","ImageObject",300,407,{"name":92,"@type":93},"Cipher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What are inflammatory bowel diseases (IBD) and why do they increase cancer risk?","Question",{"text":112,"@type":113},"IBD primarily includes ulcerative colitis and Crohn’s disease and involves chronic inflammation with epithelial barrier dysfunction and immune dysregulation, which together elevate the risk of developing cancer, particularly colorectal cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does FOSL1 connect inflammation to tumorigenesis in IBD?",{"text":117,"@type":113},"FOSL1 is induced by proinflammatory pathways such as MAPK/ERK, NF-κB, and cytokine signaling, then regulates gene programs controlling proliferation, migration, barrier integrity, immune modulation, and survival, linking inflammatory signaling to epithelial transformation and cancer progression.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the relationship between IBD-associated colorectal cancer (CRC) and chronic inflammation?",{"text":121,"@type":113},"CRC in the setting of IBD is driven by genetic and epigenetic alterations that promote abnormal epithelial proliferation, while chronic inflammation is identified as a key driver with mechanistic parallels to inflammation-linked gastrointestinal malignancies.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350327,1790632430,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},687208528416,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Review  \nThe Role of FOSL1 in Inflammatory Bowel Disease (IBD) Pathogenesis and IBD-Associated Tumorigenesis  \nGrace J. Rilee 1, Senthil K. Radhakrishnan 2,3, Guang-Yu Yang 2,3 and Jiong Li 1,3,4, *  \nAcademic Editor: Jean Sevigny  \nReceived: 20 March 2026  \nRevised: 19 April 2026  \nAccepted: 24 April 2026  \nPublished: 27 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA 23298-0540, USA  \n2 Department of Pathology, Virginia Commonwealth University, Richmond, VA 23298-0540, USA  \n3 Massey Comprehensive Cancer Center, Virginia Commonwealth University, Richmond, VA 23298-0540, USA  \n4 Center for Drug Discovery, Virginia Commonwealth University, Richmond, VA 23298-0540, USA  \n* [Correspondence: jli29@vcu.edu](Correspondence: jli29@vcu.edu)  \nAbstract  \nInflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s disease, are chronic inflammatory disorders of the gastrointestinal tract associated with epithelial barrier dysfunction, dysregulated immune responses, and an increased risk of cancer. Persistent inflammation is a key driver of IBD-associated tumorigenesis, yet the transcriptional regulators linking inflammatory signaling to epithelial transformation remain incompletely defined. FOSL1 (FOS-like antigen 1), a member of the activator protein-1 (AP-1) transcription factor family, has emerged as a critical mediator at the intersection of inflammation, epithelial homeostasis, and cancer progression. FOSL1 is induced by proinflammatory pathways commonly activated in IBD, including MAPK/ERK, NF-κB, and cytokine signaling, and regulates gene programs involved in cell proliferation, migration, barrier integrity, immune modulation, and survival. Accumulating evidence demonstrates that FOSL1 expression is elevated in inflamed intestinal mucosa and in IBD-associated malignancies, where it contributes to epithelial dysfunction, chronic inflammation, tumor initiation, metastasis, angiogenesis, and therapeutic resistance. Moreover, FOSL1-driven transcriptional networks show mechanistic overlap between IBD-associated colorectal cancer (CRC) and other inflammation-linked gastrointestinal cancers, such as pancreatic ductal adenocarcinoma (PDAC) . In this review, we summarize current knowledge on the regulation and function of FOSL1 in intestinal inflammation and IBD-associated cancers, highlight its context-dependent roles in epithelial and immune compartments, and discuss emerging therapeutic strategies aimed at indirectly targeting FOSL1 signaling pathways.  \nKeywords: FOSL1; inflammatory bowel disease; colorectal cancer; pancreatic ductaladenocarcinoma; p53  \n1. Introduction  \nInflammatory bowel diseases (IBD) are a group of chronic, relapsing inflammatory disorders of the gastrointestinal tract that consist primarily of ulcerative colitis (UC) and Crohn’s disease [1,2] . Although UC and Crohn’s disease share overlapping clinical and immunological features, these diseases differ in their distribution within the body and pathogenesis [3,4] . Crohn’s disease can affect any part of the gastrointestinal tract from the mouth to the anus and is characterized by transmural inflammation and skip lesions, whereas ulcerative colitis is limited to the colon and rectum and involves continuous mucosal inflammation [3] . The incidence and prevalence of IBD have increased globally  \nover recent decades, and mortality remains low, with the most common cases reported between the ages of 15 and 35 years [5–7] .  \nThe pathogenesis of IBD is multifaceted and involves a complex interplay between genetic susceptibility, dysregulated immune responses, intestinal microbiota alterations, and the external environment [8] . Advances in genomic and microbiome research have identifi","cbCaibQ8pAcEBITH","https://ap.wps.com/l/cbCaibQ8pAcEBITH","pdf",522160,16,"English","# Abstract\n# Keywords\n# 1. Introduction\n## 1.1 Overview of IBD subtypes and epidemiology\n## 1.2 Pathogenesis and therapeutic approaches\n## 1.3 IBD-associated colorectal cancer and underlying mechanisms\n## 1.4 Treatment landscape for CRC and relation to PDAC","[{\"question\":\"What are inflammatory bowel diseases (IBD) and why do they increase cancer risk?\",\"answer\":\"IBD primarily includes ulcerative colitis and Crohn’s disease and involves chronic inflammation with epithelial barrier dysfunction and immune dysregulation, which together elevate the risk of developing cancer, particularly colorectal cancer.\"},{\"question\":\"How does FOSL1 connect inflammation to tumorigenesis in IBD?\",\"answer\":\"FOSL1 is induced by proinflammatory pathways such as MAPK/ERK, NF-κB, and cytokine signaling, then regulates gene programs controlling proliferation, migration, barrier integrity, immune modulation, and survival, linking inflammatory signaling to epithelial transformation and cancer progression.\"},{\"question\":\"What is the relationship between IBD-associated colorectal cancer (CRC) and chronic inflammation?\",\"answer\":\"CRC in the setting of IBD is driven by genetic and epigenetic alterations that promote abnormal epithelial proliferation, while chronic inflammation is identified as a key driver with mechanistic parallels to inflammation-linked gastrointestinal malignancies.\"}]","The Role of FOSL1 in Inflammatory Bowel Disease (IBD) Pathogenesis and IBD-Associated Tumorigenesis | PDF",1790088464,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/59dab2610c4d5a22da2204b5b1c92d67.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/82baa5baafd6d1a87ac8fc8a5e5c46bf.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afc6421688d3a0ae8673cd6349f35ae3.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/508edda83b84505b275dd524268dd5f8.webp",980,1385]